Building zinc fingers by selection: toward a therapeutic application.

PubWeight™: 2.92‹?› | Rank: Top 1%

🔗 View Article (PMC 42736)

Published in Proc Natl Acad Sci U S A on January 17, 1995

Authors

H Wu1, W P Yang, C F Barbas

Author Affiliations

1: Department of Molecular Biology, Scripps Research Institute, La Jolla, CA 92037.

Articles citing this

Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A (1996) 12.25

Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol (2001) 6.68

Exploring the DNA-binding specificities of zinc fingers with DNA microarrays. Proc Natl Acad Sci U S A (2001) 5.08

Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5'-GNN-3' DNA target sequences. Proc Natl Acad Sci U S A (1999) 4.87

Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res (2000) 4.34

Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci U S A (2000) 3.92

ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool. Nucleic Acids Res (2010) 3.59

A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat Biotechnol (2001) 3.12

Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proc Natl Acad Sci U S A (1997) 2.97

Getting a handhold on DNA: design of poly-zinc finger proteins with femtomolar dissociation constants. Proc Natl Acad Sci U S A (1998) 2.51

Improved DNA binding specificity from polyzinc finger peptides by using strings of two-finger units. Proc Natl Acad Sci U S A (2001) 2.13

The Saccharomyces cerevisiae kinetochore contains a cyclin-CDK complexing homologue, as identified by in vitro reconstitution. EMBO J (1996) 1.57

Tethering human immunodeficiency virus type 1 preintegration complexes to target DNA promotes integration at nearby sites. J Virol (1997) 1.56

Genome-editing Technologies for Gene and Cell Therapy. Mol Ther (2016) 1.41

Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities. Blood (2011) 1.36

Heritable endogenous gene regulation in plants with designed polydactyl zinc finger transcription factors. Proc Natl Acad Sci U S A (2002) 1.34

Design of TATA box-binding protein/zinc finger fusions for targeted regulation of gene expression. Proc Natl Acad Sci U S A (1997) 1.31

Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases. Nucleic Acids Res (2011) 1.25

Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. Proc Natl Acad Sci U S A (2003) 1.21

Protein design: toward functional metalloenzymes. Chem Rev (2014) 1.17

Human autoantibody recognition of DNA. Proc Natl Acad Sci U S A (1995) 1.17

Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factors. Proc Natl Acad Sci U S A (2003) 1.10

Targeted methylation of the epithelial cell adhesion molecule (EpCAM) promoter to silence its expression in ovarian cancer cells. PLoS One (2014) 1.07

Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies. Acc Chem Res (2014) 1.06

Phage-displayed peptide libraries. Curr Opin Biotechnol (1998) 1.02

Determining the specificities of TALENs, Cas9, and other genome-editing enzymes. Methods Enzymol (2014) 0.93

OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions. J Gen Virol (2007) 0.92

Gene- and protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus. PLoS One (2013) 0.87

Evolution of iron(II)-finger peptides by using a bipyridyl amino acid. Chembiochem (2014) 0.84

Functional rules for lac repressor-operator associations and implications for protein-DNA interactions. Protein Sci (2010) 0.84

Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors. J Biol Chem (2012) 0.84

Recognition of diverse sequences by class I zinc fingers: asymmetries and indirect effects on specificity in the interaction between CF2II and A+T-rich elements. Proc Natl Acad Sci U S A (1996) 0.83

Transcriptional regulation of the MHC class I HLA-A11 promoter by the zinc finger protein ZFX. Nucleic Acids Res (1996) 0.82

Recognition of DNA by single-chain derivatives of the phage 434 repressor: high affinity binding depends on both the contacted and non-contacted base pairs. Nucleic Acids Res (1997) 0.81

A novel four zinc-finger protein targeted against p190(BcrAbl) fusion oncogene cDNA: utilisation of zinc-finger recognition codes. Nucleic Acids Res (2000) 0.81

Discovery of active proteins directly from combinatorial randomized protein libraries without display, purification or sequencing: identification of novel zinc finger proteins. Nucleic Acids Res (2005) 0.81

Assessment of major and minor groove DNA interactions by the zinc fingers of Xenopus transcription factor IIIA. Nucleic Acids Res (1996) 0.78

An efficient and cost-effective protocol for selecting transcription factor binding sites that reduces isotope usage. J Biomol Tech (2012) 0.76

Artificial zinc finger DNA binding domains: versatile tools for genome engineering and modulation of gene expression. J Cell Biochem (2015) 0.76

Identification of Position-Specific Correlations between DNA-Binding Domains and Their Binding Sites. Application to the MerR Family of Transcription Factors. PLoS One (2016) 0.75

Genome Engineering with TALE and CRISPR Systems in Neuroscience. Front Genet (2016) 0.75

Exploiting the recognition code for elucidating the mechanism of zinc finger protein-DNA interactions. BMC Genomics (2016) 0.75

Chemically synthesized zinc finger molecules as nano-addressable probes for double-stranded DNAs. J Nanobiotechnology (2005) 0.75

Major versus minor groove DNA binding of a bisarginylporphyrin hybrid molecule: a molecular mechanics investigation. J Comput Aided Mol Des (1999) 0.75

Articles cited by this

Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol (1990) 61.47

Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J (1985) 20.39

Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science (1991) 15.97

Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol Cell Biol (1988) 13.78

Amino acid preferences for specific locations at the ends of alpha helices. Science (1988) 8.29

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A (1991) 5.94

Zinc finger phage: affinity selection of fingers with new DNA-binding specificities. Science (1994) 5.70

Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. Science (1993) 5.38

Three-dimensional solution structure of a single zinc finger DNA-binding domain. Science (1989) 4.57

The crystal structure of a two zinc-finger peptide reveals an extension to the rules for zinc-finger/DNA recognition. Nature (1993) 3.82

In vitro selection of zinc fingers with altered DNA-binding specificity. Biochemistry (1994) 3.18

Use of a zinc-finger consensus sequence framework and specificity rules to design specific DNA binding proteins. Proc Natl Acad Sci U S A (1993) 3.09

Determination of the base recognition positions of zinc fingers from sequence analysis. EMBO J (1992) 2.31

A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1993) 2.05

Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc Natl Acad Sci U S A (1992) 1.93

A role in DNA binding for the linker sequences of the first three zinc fingers of TFIIIA. Nucleic Acids Res (1993) 1.93

Molecular basis for specific recognition of both RNA and DNA by a zinc finger protein. Science (1993) 1.75

Zinc finger-DNA recognition: analysis of base specificity by site-directed mutagenesis. Nucleic Acids Res (1992) 1.74

High-resolution three-dimensional structure of a single zinc finger from a human enhancer binding protein in solution. Biochemistry (1990) 1.64

Surface plasmon resonance for detection and measurement of antibody-antigen affinity and kinetics. Curr Opin Immunol (1993) 1.46

Solution structure of a zinc finger domain of yeast ADR1. Proteins (1990) 1.37

Zinc fingers. Sci Am (1993) 1.29

Specific interaction of the first three zinc fingers of TFIIIA with the internal control region of the Xenopus 5 S RNA gene. J Mol Biol (1992) 1.27

Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene (1994) 1.02

A permutational approach toward protein-DNA recognition. Proc Natl Acad Sci U S A (1994) 0.99

Recent advances in phage display. Curr Opin Biotechnol (1993) 0.97

Articles by these authors

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol (1995) 6.33

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A (1991) 6.13

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J Virol (1994) 5.76

Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci U S A (1998) 5.46

Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5'-GNN-3' DNA target sequences. Proc Natl Acad Sci U S A (1999) 4.87

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J Virol (1995) 4.33

Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci U S A (2000) 3.92

Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes. Science (1995) 3.82

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat Med (1997) 3.63

Development of zinc finger domains for recognition of the 5'-ANN-3' family of DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem (2001) 3.35

Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proc Natl Acad Sci U S A (1997) 2.97

Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc Natl Acad Sci U S A (1991) 2.42

Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol (1998) 2.28

Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies. J Virol (1998) 2.28

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site. AIDS (1995) 2.15

In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc Natl Acad Sci U S A (1992) 2.08

Insights into the molecular recognition of the 5'-GNN-3' family of DNA sequences by zinc finger domains. J Mol Biol (2000) 2.03

Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation (1997) 2.02

Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci U S A (1993) 2.01

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem (1999) 2.01

CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol (1995) 1.90

Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding. AIDS Res Hum Retroviruses (1996) 1.87

Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses (1997) 1.84

Human antibodies from combinatorial libraries. Adv Immunol (1994) 1.78

Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off. J Virol (1997) 1.66

Phage display of combinatorial antibody libraries. Curr Opin Biotechnol (1997) 1.56

Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12. J Virol (2001) 1.53

Custom DNA-binding proteins come of age: polydactyl zinc-finger proteins. Curr Opin Biotechnol (2001) 1.52

Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries. Nature (1992) 1.50

Human combinatorial antibody libraries to hepatitis B surface antigen. Proc Natl Acad Sci U S A (1992) 1.43

Antibodies without immunization. Science (1992) 1.41

Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc Natl Acad Sci U S A (1994) 1.40

Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion. Proc Natl Acad Sci U S A (2000) 1.40

Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure. J Immunol (1995) 1.39

T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery. Gene Ther (2006) 1.38

Aldol sensors for the rapid generation of tunable fluorescence by antibody catalysis. Proc Natl Acad Sci U S A (1998) 1.37

Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries. J Mol Biol (1997) 1.33

The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. J Biol Chem (2000) 1.32

Alphav integrins mediate adhesion and migration of breast carcinoma cell lines. Clin Exp Metastasis (1998) 1.29

Chemically regulated zinc finger transcription factors. J Biol Chem (2000) 1.29

In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope. J Virol (1996) 1.28

Methods for the generation of chicken monoclonal antibody fragments by phage display. J Immunol Methods (2000) 1.27

Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins. AIDS Res Hum Retroviruses (1997) 1.26

Multiple event activation of a generic prodrug trigger by antibody catalysis. Proc Natl Acad Sci U S A (1999) 1.21

Human autoantibody recognition of DNA. Proc Natl Acad Sci U S A (1995) 1.17

A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Eur J Biochem (2001) 1.16

An allosteric Ca2+ binding site on the beta3-integrins that regulates the dissociation rate for RGD ligands. J Biol Chem (1996) 1.14

A binary plasmid system for shuffling combinatorial antibody libraries. Proc Natl Acad Sci U S A (1992) 1.11

Functional expression of a vertebrate inwardly rectifying K+ channel in yeast. Mol Biol Cell (1995) 1.10

Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. Virology (1998) 1.08

Catalytic direct asymmetric Michael reactions: taming naked aldehyde donors. Org Lett (2001) 1.07

Design of novel sequence-specific DNA-binding proteins. Curr Opin Chem Biol (2000) 1.07

In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy. Proc Natl Acad Sci U S A (2001) 1.04

Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules. J Virol (1996) 1.03

Antibodies from libraries. Nature (1992) 1.02

Phenotypic revertant mutations of a new OmpR2 mutant (V203Q) of Escherichia coli lie in the envZ gene, which encodes the OmpR kinase. J Bacteriol (1993) 1.01

Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1. Acta Crystallogr D Biol Crystallogr (2001) 1.01

Two types of calcium channels in bullfrog saccular hair cells. Hear Res (1995) 0.98

On the use of combinatorial antibody libraries to clone the "fossil record" of an individual's immune response. Proc Natl Acad Sci U S A (1991) 0.98

The antibody catalysis route to the total synthesis of epothilones. Proc Natl Acad Sci U S A (1998) 0.96

Molecular cloning, nucleotide sequence and fine-structural analysis of the Corynebacterium glutamicum fda gene: structural comparison of C. glutamicum fructose-1,6-biphosphate aldolase to class I and class II aldolases. Mol Microbiol (1989) 0.96

Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization. J Biol Chem (2000) 0.95

The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries. Anal Biochem (1998) 0.95

The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection. Proc Natl Acad Sci U S A (1994) 0.94

Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein. Mol Med (1998) 0.93

Human antibodies to HIV-1 by recombinant DNA methods. Chem Immunol (1993) 0.92

On roads not taken in the evolution of protein catalysts: antibody steroid isomerases that use an enamine mechanism. Proc Natl Acad Sci U S A (1997) 0.91

Response of C3H/10T1/2 fibroblasts to an external steady electric field stimulation. Reorientation, shape change, ConA receptor and intramembranous particle distribution and cytoskeleton reorganization. Exp Cell Res (1984) 0.90

Drug-inducible and simultaneous regulation of endogenous genes by single-chain nuclear receptor-based zinc-finger transcription factor gene switches. Gene Ther (2008) 0.90

Genomic organization and expression of KCNJ8/Kir6.1, a gene encoding a subunit of an ATP-sensitive potassium channel. Gene (1998) 0.90

Direct selection for a catalytic mechanism from combinatorial antibody libraries. Proc Natl Acad Sci U S A (1994) 0.90

A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries. Proc Natl Acad Sci U S A (1998) 0.90

Identification of a region in the integrin beta3 subunit that confers ligand binding specificity. J Biol Chem (1997) 0.89

Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task. Proc Natl Acad Sci U S A (2000) 0.89

Recombinant rabbit Fab with binding activity to type-1 plasminogen activator inhibitor derived from a phage-display library against human alpha-granules. Gene (1996) 0.84

Surface plasmon resonance based kinetic studies of zinc finger-DNA interactions. J Immunol Methods (1995) 0.84

An efficient benchtop system for multigram-scale kinetic resolutions using aldolase antibodies. Chemistry (2000) 0.84

Effect of C-peptide administration on whole body glucose utilization in STZ-induced diabetic rats. Acta Physiol Scand (1996) 0.83

Role of leukocytes in the activation of intravascular coagulation in patients with septicemia. Am J Hematol (1991) 0.83

Building synthetic antibodies as adhesive ligands for integrins. J Biol Chem (1994) 0.83

Benzoate X receptor zinc-finger gene switches for drug-inducible regulation of transcription. Gene Ther (2011) 0.83

Human monoclonal antibodies: recent achievements. Hosp Pract (Off Ed) (1994) 0.83

Sets of aldolase antibodies with antipodal reactivities. Formal synthesis of epothilone E by large-scale antibody-catalyzed resolution of thiazole aldol. Org Lett (1999) 0.82

A point mutation in the chloroplast rps12 gene from Nicotiana plumbaginifolia confers streptomycin resistance. Plant Mol Biol (1993) 0.78

Functional display of human plasminogen-activator inhibitor 1 (PAI-1) on phages: novel perspectives for structure-function analysis by error-prone DNA synthesis. Gene (1993) 0.78

House dust mite asthma in China: a review. Ann Allergy (1987) 0.77

Making enzymes. Harvey Lect (2004) 0.76

Synthesis of five enantiomerically pure haptens designed for in vitro evolution of antibodies with peptidase activity. Bioorg Med Chem (1996) 0.76

Visualizing antibody-catalyzed retro-aldol-retro-Michael reactions. Bioorg Med Chem Lett (2001) 0.76

Interruption of pregnancy in the rat by administration of ACTH. Endocrinology (1969) 0.76

Synthesis of an organoinsulin molecule that can be activated by antibody catalysis. Proc Natl Acad Sci U S A (2001) 0.75

Alchemy, enzymes, and the blind-watchmaker. Nat Biotechnol (1998) 0.75

Enantioselective aldol cyclodehydrations catalyzed by antibody 38C2. Org Lett (1999) 0.75

Purification of storage granule protein-23. A novel protein identified by phage display technology and interaction with type I plasminogen activator inhibitor. J Biol Chem (1996) 0.75

[Relationship between the plasma levels of soluble fibrin monomer and the formation of soluble fibrin monomer complex (SFMC)]. Rinsho Byori (1989) 0.75

Retracted Simultaneous, phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody enhances antiangiogenic effects in vivo. Klin Padiatr (2006) 0.75

[Studies on the spectroscopic property of p-hydroxyphenol derivatives]. Guang Pu Xue Yu Guang Pu Fen Xi (2001) 0.75

[Studies on the changes in infection rates of whipworm and ascaris in population after continuous chemotherapy]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (1993) 0.75